Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
25.0%
% of IDNA's 43 holdings also in GNOM
24.4%
% of GNOM's 41 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 4.1% | 4.5% | 4.1% |
 |
INTELLIA THERAPEUTICS, INC. | 4.3% | 3.8% | 3.8% |
|
BEAM THERAPEUTICS, INC. | 4.6% | 3.7% | 3.7% |
|
MODERNA, INC. | 5.4% | 2.5% | 2.5% |
|
GILEAD SCIENCES INC | 5.7% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to GNOM
 |
GENMAB A/S | 6.1% |
 |
BEIGENE, LTD. | 5.2% |
|
REGENERON PHARMACEUTICALS | 4.6% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 4.1% |
|
ONO PHARMACEUTICAL CO LTD | 4.1% |
 |
ROCHE HOLDING LTD | 3.9% |
|
EXELIXIS INC | 3.7% |
|
VIR BIOTECHNOLOGY, INC. | 3.6% |
 |
SANOFI-AVENTIS | 3.3% |
|
FATE THERAPEUTICS INC | 3.3% |
IDNA Underweight Relative to GNOM
|
10X GENOMICS INC CLASS A | -5.1% |
|
AGILENT TECHNOLOGIES INC | -4.5% |
|
BIO-TECHNE CORPORATION | -4.5% |
|
QIAGEN NV | -4.4% |
|
ALNYLAM PHARMACEUTICALS INC | -4.2% |
|
BIOMARIN PHARMACEUTICAL INC | -4.2% |
|
SAREPTA THERAPEUTICS INC | -4.0% |
|
CRISPR THERAPEUTICS AG | -4.0% |
|
ILLUMINA INC | -3.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |